Evolent Health (EVH) Operating Expenses (2016 - 2025)
Evolent Health has reported Operating Expenses over the past 11 years, most recently at $877.0 million for Q4 2025.
- Quarterly results put Operating Expenses at $877.0 million for Q4 2025, up 31.84% from a year ago — trailing twelve months through Dec 2025 was $2.3 billion (down 11.9% YoY), and the annual figure for FY2025 was $2.3 billion, down 11.9%.
- Operating Expenses for Q4 2025 was $877.0 million at Evolent Health, up from $478.6 million in the prior quarter.
- Over the last five years, Operating Expenses for EVH hit a ceiling of $877.0 million in Q4 2025 and a floor of $229.1 million in Q3 2021.
- Median Operating Expenses over the past 5 years was $462.1 million (2025), compared with a mean of $460.8 million.
- Biggest five-year swings in Operating Expenses: crashed 48.16% in 2021 and later skyrocketed 55.74% in 2023.
- Evolent Health's Operating Expenses stood at $260.6 million in 2021, then soared by 47.49% to $384.3 million in 2022, then skyrocketed by 50.24% to $577.4 million in 2023, then increased by 15.19% to $665.1 million in 2024, then skyrocketed by 31.84% to $877.0 million in 2025.
- The last three reported values for Operating Expenses were $877.0 million (Q4 2025), $478.6 million (Q3 2025), and $445.5 million (Q2 2025) per Business Quant data.